1-6 of 6
Karamjit Gill
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation

Pedro Farinha, Abdulwahab Al-Tourah, Karamjit Gill, Richard Klasa, Joseph M. Connors, Randy D. Gascoyne
Journal: Blood
Blood (2010) 115 (2): 289–295.
https://doi.org/10.1182/blood-2009-07-235598
Published: 2010
Journal Articles

Outcome in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CHOP-R Can Be Predicted by Stage and Serum Lactate Dehydrogenase (LDH) Level.

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry J. Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2006) 108 (11): 2739.
https://doi.org/10.1182/blood.V108.11.2739.2739
Published: 2006
Journal Articles

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP

Clinical Trials & Observations
Laurie H. Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J. Savage, Tamara Shenkier, Judy Sutherland, Randy D. Gascoyne, Joseph M. Connors
Journal: Blood
Blood (2006) 109 (5): 1857–1861.
https://doi.org/10.1182/blood-2006-08-038257
Published: 2006
Journal Articles

Revised International Prognostic Index (R-IPI) Is a Better Predictor of Outcome Than the Standard IPI for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Treated with Rituximab and CHOP (R-CHOP).

Laurie H. Sehn, MD, MPH, Mukesh Chhanabhai, MD, Catherine Fitzgerald, MD, Karamjit Gill, MD, Paul Hoskins, MD, Richard Klasa, MD, Kerry Savage, MD, Tamara Shenkier, MD, Judy Sutherland, MD, Kenneth Wilson, MD, Randy D. Gascoyne, MD, Joseph M. Connors, MD
Journal: Blood
Blood (2005) 106 (11): 492.
https://doi.org/10.1182/blood.V106.11.492.492
Published: 2005
Journal Articles

Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)

Clinical Trials & Observations
Pedro Farinha, Hamid Masoudi, Brian F. Skinnider, Karey Shumansky, John J. Spinelli, Karamjit Gill, Richard Klasa, Nicolas Voss, Joseph M. Connors, Randy D. Gascoyne
Journal: Blood
Blood (2005) 106 (6): 2169–2174.
https://doi.org/10.1182/blood-2005-04-1565
Published: 2005
Journal Articles

Lymphoma-Associated Macrophage (LAM) Content Is an Independent Predictor of Survival in Patients with Follicular Lymphoma (FL).

Pedro Farinha, Hamid Masoudi, Brian Skinnider, Karey Shumansky, John Spinelli, Karamjit Gill, Richard Klasa, Joseph M. Connors, Randy D. Gascoyne
Journal: Blood
Blood (2004) 104 (11): 3259.
https://doi.org/10.1182/blood.V104.11.3259.3259
Published: 2004